台股 » 個股 » 慧智 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

慧智

(6615)
  • 股價
    43.50
  • 漲跌
    ▼1.30
  • 漲幅
    -2.90%
  • 成交量
    78
  • 產業
    上櫃 生技醫療類股▼0.71%
  • 41人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
慧智 (6615)籌碼相關-元大-鹿港 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-鹿港 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/13144.0000.0043.501881.13%
2024/05/0600.00149.9049.35-181-1.22%
2024/04/26148.4000.0048.301661.51%
2024/04/1100.00141.0040.90-136-2.75%
2023/11/3000.00140.0040.00-112-8.12%
2023/11/15138.8500.0039.551118.40%
2023/10/1200.00139.2538.85-136-2.73%
2023/10/11139.0000.0039.301362.72%
2023/08/0900.00143.1043.10-156-1.79%
2023/08/0400.00444.5545.65-472-5.55%
2023/08/02145.1000.0044.951771.28%
2023/08/01445.41546.0246.85-173-1.37%
2023/07/1800.00138.6037.55-161-1.64%
2023/07/11138.3500.0038.851601.66%
2023/07/07238.4000.0038.852603.33%
2023/07/0600.00239.8839.85-259-3.38%
2023/07/05139.4500.0039.951591.69%
2023/07/03139.5500.0040.001581.71%
2023/06/13140.7000.0040.651571.75%
2023/06/02242.5300.0042.252523.79%
2023/05/2400.00143.6544.80-148-2.04%
2023/05/23143.0000.0043.501472.10%
2023/03/17137.9000.0038.001127.99%
2021/06/1500.00554.1455.10-548-10.41%
2021/06/11551.8000.0051.8054311.62%
2021/05/21146.7000.0046.701432.28%
2020/10/13157.5000.0057.501156.65%
2019/02/2200.002109.00114.00-2175-1.14%
2019/02/1800.001107.00107.00-1150-0.67%
2019/02/1500.004103.50105.00-4142-2.81%
2018/12/2000.00193.0092.80-1111-0.90%
2018/12/19193.4000.0094.7011090.91%
2018/11/21179.0000.0080.801981.02%
2018/10/25282.0000.0081.5021331.50%
2018/10/11490.9000.0090.7041492.67%
2018/05/1800.001146.00136.50-1457-0.22%
2018/05/151144.0000.00144.5014330.23%
2018/04/0900.008117.50117.50-8245-3.26%
2018/03/2600.00188.4095.00-1214-0.47%
2018/03/23188.5000.0088.5012090.48%
2018/03/2200.003100.0093.00-3201-1.49%
2018/03/213101.5000.00102.0031911.56%
2018/02/0100.00284.2084.20-2133-1.50%
2018/01/24289.3000.0088.9021191.67%
2018/01/23389.7300.0088.0031162.57%
〈熱門股〉次世代基因定序明年納健保 創源、慧智帶量上攻Anue鉅亨-2023/08/05
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
慧智 相關文章
慧智 相關影音